Professor Dr. Markus Hoth

Address Universität des Saarlandes
CIPMM - Center for Integrative Physiology and Molecular Medicine
Kirrberger Straße
66424 Homburg

Projects

As Applicant
- Completed projects
  - Calcium signaling in T-cells from human intestinal mucosa: Characterization, regulation and functional importance including the role for IBD (Intestinal Bowel Disease) (Research Grants)
  - A dual STIM2 redox switch in melanoma immunology (Priority Programmes)
As Leader
- Completed projects
  - Vollautomatisches konfokales Fluoreszenzmikroskop (Major Research Instrumentation)
  - Total Internal Reflection Fluorescence (TIRF) Mikroskopie-Messplatz (Major Research Instrumentation)
  - Lightsheet Mikroskop (Major Research Instrumentation)
  - Tisch-Durchflusszytometer (Major Research Instrumentation)
  - Screening microscope with confocal functionality (Major Research Instrumentation)
As Participating Researcher
- Completed projects
  - GRK 377: Cellular Regulation and Growth (Research Training Groups)
  - GRK 845: Molecular, Physiological and Pharmacological Analysis of Cellular Membrane Transport (Research Training Groups)
  - GRK 1326: Calcium-Signalling and Cellular Nanodomains (Research Training Groups)
  - GRK 1830: Complex Membrane Proteins in Cellular Development and Disease (International Research Training Groups)
As Project Head
- Completed projects
  - Subcellular analysis of T-cell activation (Collaborative Research Centres)
  - Ca2+-dependent CTL and NK cell cytotoxicity (Collaborative Research Centres)
  - Dynamics of polarization of T cells and NK cells (Collaborative Research Centres)
  - Killing efficiency of cytotoxic T lymphocytes and natural killer cells against cancer cells (Collaborative Research Centres)
As Participating Person
- Completed projects
  - Untersuchungen zur Rolle der SNARE Proteine bei der Funktion von zytotoxischen T-Lymphozyten (Research Grants)
  - Collective phenomena in cytoskeletal dynamics during formation of immunological synapses (Research Grants)
  - Analysis and therapeutic targeting of the metabolic and proliferative tumor heterogeneity in malignant melanoma (Research Grants)